5.1.Market Drivers42
5.1.1.Demand from biopharmaceutical production, vaccine development, and life science research43
5.1.2.Growth of biologics including monoclonal antibodies, cell-based tests and regenerative medicine45
5.1.3.Shift towards serum-free and chemically defined formulations47
5.2.Market Restraints50
5.3.Market Opportunities54
6.1.Market Share & Positioning58
6.2.Key Strategies by Players61
6.3.Porter Five Forces Analysis64